CRIS Current Research Information System

SABATTINI, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.753
AS - Asia 8.100
NA - Nord America 6.725
SA - Sud America 530
AF - Africa 445
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 1
Totale 25.595
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.573
IT - Italia 5.636
CN - Cina 2.180
SG - Singapore 2.142
VN - Vietnam 2.075
GB - Regno Unito 904
DE - Germania 601
SE - Svezia 547
HK - Hong Kong 509
FR - Francia 430
BR - Brasile 378
IN - India 325
NL - Olanda 322
RU - Federazione Russa 238
KR - Corea 235
JP - Giappone 176
FI - Finlandia 171
IE - Irlanda 164
UA - Ucraina 135
ZA - Sudafrica 127
CH - Svizzera 125
SC - Seychelles 96
TG - Togo 88
CI - Costa d'Avorio 87
BG - Bulgaria 78
MX - Messico 74
AR - Argentina 61
ID - Indonesia 60
CA - Canada 57
ES - Italia 55
PH - Filippine 50
EE - Estonia 49
AT - Austria 46
PL - Polonia 43
TW - Taiwan 42
BD - Bangladesh 41
BE - Belgio 40
IQ - Iraq 37
TH - Thailandia 37
JO - Giordania 36
GR - Grecia 31
PT - Portogallo 31
AU - Australia 30
TR - Turchia 27
PK - Pakistan 24
CL - Cile 23
EC - Ecuador 23
RO - Romania 23
LT - Lituania 20
CO - Colombia 17
SA - Arabia Saudita 16
UZ - Uzbekistan 14
HR - Croazia 13
NZ - Nuova Zelanda 11
PE - Perù 11
SI - Slovenia 11
AE - Emirati Arabi Uniti 9
MY - Malesia 9
HU - Ungheria 8
KZ - Kazakistan 8
DK - Danimarca 7
MA - Marocco 7
NG - Nigeria 7
VE - Venezuela 7
GE - Georgia 6
IL - Israele 6
PY - Paraguay 6
TN - Tunisia 6
DZ - Algeria 5
IR - Iran 5
NO - Norvegia 5
SK - Slovacchia (Repubblica Slovacca) 5
CZ - Repubblica Ceca 4
ET - Etiopia 4
KE - Kenya 4
LB - Libano 4
AF - Afghanistan, Repubblica islamica di 3
AL - Albania 3
AM - Armenia 3
AZ - Azerbaigian 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
JM - Giamaica 3
OM - Oman 3
SM - San Marino 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
CR - Costa Rica 2
GH - Ghana 2
MZ - Mozambico 2
NP - Nepal 2
PA - Panama 2
SV - El Salvador 2
BJ - Benin 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
EG - Egitto 1
Totale 25.571
Salva come PNG Salva come JPEG
Città #
Singapore 1.459
Ashburn 753
Southend 680
Milan 548
Ho Chi Minh City 488
Hong Kong 488
Chandler 476
Fairfield 438
Hefei 423
San Jose 407
Rome 373
Hanoi 367
Santa Clara 353
Dong Ket 347
Bologna 323
Ann Arbor 286
Beijing 240
Woodbridge 212
Wilmington 206
Seattle 205
Princeton 204
Seoul 195
Houston 186
Dublin 161
Cambridge 155
Dallas 150
Boardman 143
Turin 138
Helsinki 129
Council Bluffs 128
Florence 126
Los Angeles 117
Lauterbourg 115
Tokyo 103
New York 101
Naples 95
Frankfurt am Main 94
Lomé 88
Abidjan 86
Nanjing 80
Westminster 79
Sofia 75
Padova 73
Genoa 66
Berlin 65
Guangzhou 65
Brescia 58
Zurich 57
Buffalo 55
Da Nang 55
Haiphong 54
Jinan 52
Redondo Beach 52
Jacksonville 51
Palermo 51
São Paulo 50
Orem 45
Shenyang 45
Johannesburg 43
Medford 43
Redmond 42
Shanghai 42
Redwood City 40
Bari 39
Bengaluru 38
San Diego 37
Brussels 36
Dearborn 36
Amman 35
Changsha 35
Jakarta 33
Saint Petersburg 33
Munich 32
Verona 32
London 31
Nuremberg 31
Parma 31
Ancona 30
Des Moines 30
Tianjin 30
Hebei 29
Hyderabad 29
Modena 29
Phoenix 27
Amsterdam 26
Lappeenranta 26
Messina 26
Monza 26
Hải Dương 25
Paris 25
Cesena 24
Hangzhou 24
Jiaxing 24
Moscow 24
Warsaw 24
Nanchang 23
Catania 22
Cagliari 21
Thái Nguyên 21
Brooklyn 20
Totale 13.988
Salva come PNG Salva come JPEG
Nome #
Attività antitumorale di un nuovo farmaco in due casi di linfoma cutaneo felino non responsivi a lomustina 1.457
Indicatori istopatologici di prognosi nel mastocitoma cutaneo e viscerale del gatto 1.238
Aspetto citologico, grado istologico, margini chirurgici e immunoistochimica del mastocitoma canino: in aiuto al clinico 1.073
Grading citologico del mastocitoma cutaneo del cane 772
Istologia, immunoistochimica e c-Kit nel mastocitoma felino: quanto servono al clinico? 644
The 2-tier grading system identifies canine cutaneous and/or subcutaneous mast cell tumors with aggressive biological behavior regardless of growth model 342
Comparison between May-Grünwald-Giemsa and rapid cytological stains in fine-needle aspirates of canine mast cell tumour: Diagnostic and prognostic implications 320
Emangiosarcoma: aspetti istopatologici e marker diagnostici 317
Feline large granular lymphocyte lymphoma: An Italian Society of Veterinary Oncology (SIONCOV) retrospective study 295
Intraoperative methylene blue staining is effective as a single mapping technique in the identification of sentinel lymph nodes in dogs with low‐grade mast cell tumours 253
Canine Splenic Nodular Lymphoid Lesions: Immunophenotyping, Proliferative Activity, and Clonality Assessment 248
Comparison between May Grünwald-Giemsa and rapid stains in fine-needle aspirates of canine mast cell tumor: diagnostic and prognostic implications 242
Linee guida SIONCOV 2023 per diagnosi, stadiazione e trattamento del carcinoma uroteliale di vescica e uretra del cane 237
Cytological differentiation between benign and malignant perianal gland proliferative lesions in dogs: a preliminary study 234
Prevalence of p53 dysregulations in feline oral squamous cell carcinoma and non-neoplastic oral mucosa 230
Adjuvant medical therapy provides no therapeutic benefit in the treatment of dogs with low-grade mast cell tumours and early nodal metastasis undergoing surgery 229
Environmental risk factors for the development of oral squamous cell carcinoma in cats 226
Expression of cannabinoid and cannabinoid-related receptors in the oral mucosa of healthy cats and cats with chronic gingivostomatitis 217
Papillomavirus associated malignancies in dogs and cats 216
Comparative Assessment of the Accuracy of Cytological and Histologic Biopsies in the Diagnosis of Canine Bone Lesions 214
An Evolutionary Cancer Epigenetic Approach Revealed DNA Hypermethylation of Ultra-Conserved Non-Coding Elements in Squamous Cell Carcinoma of Different Mammalian Species 214
Analysis of DNA methylation and TP53 mutational status for differentiating feline oral squamous cell carcinoma from non-neoplastic mucosa: A preliminary study 213
Assessment of PDGFRβ promoter methylation in canine osteosarcoma using methylation-sensitive high-resolution melting analysis 208
Mastociti in circolo: semplici spettatori o partecipanti attivi? Controversie, diagnosi e prognosi della mastocitosi/mastocitemia felina 206
Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision 203
Comparison between May Grünwald-Giemsa and rapid stains in fine-needle aspirates of canine mast cell tumours: diagnostic and prognostic implications. 201
A retrospective Italian Society of Veterinary Oncology (SIONCOV) study of 56 cats with appendicular osteosarcoma 199
Comparison of 2- and 3-category histologic grading systems for predicting the presence of metastasis at the time of initial evaluation in dogs with cutaneous mast cell tumors: 386 cases (2009–2014) 197
Ultrasonographic honeycomb pattern of the spleen in cats: correlation with pathological diagnosis in 33 cases 197
EGFR expression is predictive of a poor prognosis in feline cutaneous squamous cell carcinoma. 195
Opportunities and challenges of active immunotherapy in dogs with B-cell lymphoma: a 5-year experience in two veterinary oncology centers 194
A retrospective study on prophylactic regional lymphadenectomy versus nodal observation only in the management of dogs with stage I, completely resected, low-grade cutaneous mast cell tumors 194
Outcome comparison between radiation therapy and surgery as primary treatment for dogs with periarticular histiocytic sarcoma: An Italian Society of Veterinary Oncology study 193
Enhanced therapeutic effect of APAVAC immunotherapy in combination with dose-intense chemotherapy in dogs with advanced indolent B-cell lymphoma 191
Comparison of definitive-intent finely fractionated and palliative-intent coarsely fractionated radiotherapy as adjuvant treatment of feline microscopic injection-site sarcoma 191
Periarticular histiocytic sarcoma with heart metastasis in a cat 191
Timely adjuvant chemotherapy improves outcome in dogs with non-metastatic splenic hemangiosarcoma undergoing splenectomy 189
Longitudinal lymph node step-sectioning for the identification of metastatic disease in canine mast cell tumor 187
Adjuvant dose-intense versus metronomic chemotherapy for dogs with metastatic splenic hemangiosarcoma: a multi-institutional retrospective study. 186
Combination of radiation therapy and firocoxib for the treatment of canine nasal carcinoma 185
Prognostic value of peripheral blood and bone marrow infiltration assessed by flow cytometry in dogs with de novo nodal peripheral T-cell lymphoma receiving alkylating-rich chemotherapy 182
Enhanced therapeutic effect of APAVAC vaccine in combination with dose-intense chemotherapy in dogs with clinically-advanced multicentric indolent B-cell lymphoma. 182
Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain 179
SIONCOV guidelines for diagnosis, staging, and treatment of feline intestinal lymphoma 175
Reclassification of 21 presumptive canine peripheral nerve sheath tumors (pnst) using a literature-based immunohistochemical panel 174
A retrospective analysis of chemotherapy switch suggests improved outcome in surgically removed, biologically aggressive canine haemangiosarcoma 174
Lymphadenectomy improves outcome in dogs with resected Kiupel high-grade cutaneous mast cell tumours and overtly metastatic regional lymph nodes 172
Treatment of oral squamous cell carcinoma in a horse by surgical debulking followed by metronomic chemotherapy 170
Features and prognostic impact of distant metastases in 45 dogs with de novo stage IV cutaneous mast cell tumours: A prospective study 170
Grading Cutaneous Mast Cell Tumors in Cats 169
Clinical relevance of simultaneous histopathological grading of canine cutaneous mast cell tumors at first presentation: a retrospective study on 386 cases. 169
P16 immunostaining of canine squamous cell carcinomas is not associated with papillomaviral DNA 169
Histologic grade has a higher-weighted value than nodal status as predictor of outcome in dogs with cutaneous mast cell tumours and overtly metastatic sentinel lymph nodes 168
A Phase 2, Single-Arm, Open-Label Clinical Trial on Adjuvant Peptide-Based Vaccination in Dogs with Aggressive Hemangiosarcoma Undergoing Surgery and Chemotherapy 167
Prognostic Value of Histologic and Immunohistochemical Features in Feline Cutaneous Mast Cell Tumors 167
Metastatic Adenocarcinoma of Unknown Primary Origin Presenting with Severe Lumbar Neuropathic Pain in a Dog 167
Airway Remodeling in Feline Lungs 166
Subcutaneous mast cell tumours: A prospective multi-institutional clinicopathological and prognostic study of 43 dogs 165
Evaluation of Ki-67 expression in feline non-ocular melanocytic tumours 164
Clinical Features and Outcome of 79 Dogs With Digital Squamous Cell Carcinoma Undergoing Treatment: A SIONCOV Observational Study 164
Sleeping Beauty: Anesthesia May Promote Relapse in Dogs With Diffuse Large B-Cell Lymphoma in Complete Remission After Chemo-Immunotherapy 164
COMPARISONS AMONG COMPUTED TOMOGRAPHIC FEATURES OF ADIPOSE MASSES IN DOGS AND CATS 162
A Retrospective Clinico-Pathologic Study of 35 Dogs with Urethral Transitional Cell Carcinoma Undergoing Treatment 159
Comparison of sonographic and CT findings for the identification of renal nodules in dogs and cats 158
Esperienze cliniche ed anatomopatologiche sulla c.d. Pancitopenia Neonatale del bovino. Nota preliminare 158
Clinicopathologic features and biologic behavior of canine splenic nodules with stromal, histiocytic and lymphoid components 157
ASSESSMENT OF EGFR AND HER-2 EXPRESSION AND ERAS-STATUS IN CANINE GASTRIC TUMOURS 156
Chemo-switch improves outcome in surgically-removed, biologically aggressive canine hemangiosarcoma. 156
EGFR Expression is Predictive of Poor Prognosis in Feline Cutaneous Squamous Cell Carcinoma 155
Conformity and controversies in the diagnosis, staging and follow-up evaluation of canine nodal lymphoma: a systematic review of the last 15 years of published literature 154
Histopathological findings and proliferative activity of canine sebaceous gland tumours with a predominant reserve cell population 153
Immunohistochemical prognosticators in feline cutaneous and visceral mast cell tumors. 151
Prognostic Significance of Kit Receptor Tyrosine Kinase Dysregulations in Feline Cutaneous Mast Cell Tumors 150
Validation of oral brushing as a non-invasive technique for the identification of feline oral squamous cell carcinoma by DNA methylation and TP53 mutation analysis 150
Immunohistochemical characterization of therapeutic targets in canine bladder cancer 149
EGFR overexpression in canine primary lung cancer: pathogenetic implications and impact on survival 149
Feline large granular lymphocyte lymphoma: an Italian Society of Veterinary Oncology (SIONCOV) retrospective study. 147
COMPARISON OF A HYPOFRACTIONATED VERSUS A FULL-COURSE RADIOTHERAPY PROTOCOL FOR THE TREATMENT OF MICROSCOPIC CUTANEOUS MAST CELL TUMOURS IN DOGS. 146
Prognosis following surgical excision in canine and feline malignant skin tumors: the role of the histological evaluation of margins. 145
EGFR expression and air pollution carcinogenesis in canine primary lung tumours 145
EGFR, HER-2 and KRAS in Canine Gastric Epithelial Tumors: A Potential Human Model? 145
Combination of radiation therapy and a selective COX-2 inhibitor (firocoxib) in the treatment of canine nasal carcinomas 144
Kit receptor tyrosine kinase dysregulations in feline splenic mast cell tumours 143
A Target Animal Effectiveness Study on Adjuvant Peptide-Based Vaccination in Dogs with Non-Metastatic Appendicular Osteosarcoma Undergoing Amputation and Chemotherapy 143
Patterns of nodal metastases, biological behaviour and prognosis of canine mast cell tumours of the pinna: A multi-institutional retrospective study 142
Role of CT in the Staging of Colorectal Tumors: A Preliminary Study on 10 Dogs 141
Immunohistochemical Analysis of Canine Haemangioma and Haemangiosarcoma 140
CLINICAL OUTCOME OF DOGS WITH UROTHELIAL CARCINOMA TREATED WITH DOSE-INTENSE CHEMOTHERAPY VERSUS RADIO-CHEMOTHERAPY: A SINGLE-INSTITUTIONAL PROSPECTIVE UNBLINDED STUDY. 140
A phase 2, single-arm, open-label clinical trial on adjuvant active immunotherapy in dogs with appendicular osteosarcoma undergoing amputation and chemotherapy 138
Incorporation of Biologic Variables Into the Staging for Canine Cutaneous and Subcutaneous Mast Cell Tumours: Proposal of the UBo pTNM System 136
A phase 2, single-arm, open-label clinical trial on adjuvant peptide-based anticancer vaccination in dogs with biologically aggressive hemangiosarcoma undergoing surgery and chemotherapy: preliminary results of an ongoing study 134
EGFR expression is predictive of a poor prognosis in feline cutaneous squamous cell carcinoma 134
Adjuvant Chemotherapy Is Associated With Prolonged Survival Time in Small-Breed Dogs Undergoing Amputation for Appendicular Osteosarcoma 133
Differentiating feline inflammatory bowel disease from alimentary lymphoma in duodenal endoscopic biopsies 133
Circulating nucleosomes as a potential cancer biomarker in dogs with splenic nodular lesions 130
Histological grading of canine mast cell tumor: is two better than three? 130
Comparison of two radiation protocols for feline injection site sarcoma. 130
Expression Profile of Twelve Transcripts as a Supporting Tool for the Molecular Characterization of Canine Cutaneous Mast Cell Tumors at Diagnosis: Association with Histological Grading and Clinical Staging 129
Feline intestinal mast cell tumours: clinicopathological characterisation and KIT mutation analysis 126
Ki-67 assessment—agreeability between immunohistochemistry and flow cytometry in canine lymphoma 125
Totale 22.131
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.975
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021842 0 0 0 0 0 0 0 0 0 140 108 594
2021/20222.035 172 94 90 190 243 168 73 139 105 118 351 292
2022/20232.707 248 362 158 282 162 282 110 174 415 119 264 131
2023/20241.840 109 193 111 125 142 221 151 121 76 198 192 201
2024/20254.750 361 582 365 371 639 269 428 230 205 324 301 675
2025/20269.550 728 1.225 883 730 1.089 547 1.051 539 2.035 723 0 0
Totale 26.041